Πέμπτη, 12 Σεπτεμβρίου 2013«Αμείωτο

Πέμπτη, 12 Σεπτεμβρίου 2013«Αμείωτο συνεχίζεται το «πάρτυ» προμήθειας βηματοδοτών-απινιδωτών και συνολική επιβάρυνση για το δημόσιο 9 εκατ. ευρώ για το 2012 και περίπου 800.000 κάθε μήνα για το τρέχον έτος»
Κύριε Υπουργέ,

με αμείωτη ένταση συνεχίζεται το πάρτυ κερδοσκοπίας στις προμήθειες του ΕΣΥ, την ώρα που οι Έλληνες ασφαλισμένοι υφίστανται συνεχείς αφαιμάξεις στην ιατροφαρμακευτική τους περίθαλψη. Εκτός από... την οικονομική παράμετρο της συγκεκριμένης προμήθειας, τίθεται όμως και ζήτημα επιστημονικό, καθώς αφενός οι συσκευές που αγοράστηκαν δεν αποτελούν προϊόντα εξελιγμένης τεχνολογίας (είναι μοντέλα του 2003), ενώ σε ό,τι αφορά τους απινιδωτές έχει διαμορφωθεί κατάσταση μονοπωλίου, με έναν και μόνο αντιπρόσωπο να έχει την ευθύνη για την προμήθεια και τη συντήρηση των συσκευών κρατώντας έτσι σε μία ιδιότυπη «ομηρία» τους Έλληνες καρδιοπαθείς που ζουν με εμφυτεύσιμο απινιδωτή.

Σε ότι αφορά τον διαγωνισμό της ΕΠΥ, για την σχετική προμήθεια, αυτός δήρκεσε 863 ημέρες (!) και με απόφασή της στις 14 Δεκεμβρίου 2012 η Επιτροπή Προμηθειών Υγείας (ΕΠΥ) κατακύρωσε ως προμηθευτές βηματοδοτών όλων των δημόσιων και στρατιωτικών νοσοκομείων για τη διετία 2013- 2014 , δύο μεγάλες πολυεθνικές εταιρίες δια των Ελλήνων αντιπρόσωπων τους. Ο ένας εξ αυτών, όπως αναφέρουν διάφορα δημοσιεύματα, επικράτησε και στους απινιδωτές. Η προμήθεια αφορούσε 5.000 βηματοδότες και 700 απινιδωτές, συνολικής αξίας 13,5 εκατ. ευρώ, με το ήμισυ του ποσού να αφορά τους απινιδωτές.

Επρόκειτο αναμφίβολα για έναν «μαραθώνιο» - διαγωνισμό, καθώς διήρκεσε 863 ημέρες. Η ΕΠΥ προκήρυξε τον διαγωνισμό για την προμήθεια βηματοδοτών- απινιδωτών για τα νοσοκομεία του ΕΣΥ στις 24 Σεπτεμβρίου 2010 και οι συμφωνίες της ΕΠΥ με τις επικρατούσες εταιρίες υπογράφηκαν πριν από έναν περίπου μήνα, στις 4 Φεβρουαρίου 2013.

Σύμφωνα με τα στοιχεία που έχει στη διάθεσή του το protothema.gr, το 2012 οι τιμές των βηματοδοτών και των απινιδωτών ίδιου τύπου και ίδιας παλαιότητας στην Ελλάδα και την Κύπρο παρουσιάζουν απόκλιση πολλών εκατοντάδων ευρώ. Ενδεικτικά, ένας βηματοδότης τύπου SENSIA SESR01 στην Ελλάδα κοστίζει 1.346 ευρώ ενώ στην Κύπρο το ίδιο μοντέλο διατίθεται στο 1/3 της «ελληνικής» τιμής.

Άλλος βηματοδότης αξίας 1.812 ευρώ στην χώρα μας, διατίθεται στην Κύπρο 709 ευρώ, δηλαδή ο βηματοδότης είναι 156% πιο ακριβός στην Ελλάδα. Το ίδιο συμβαίνει με όλα τα μοντέλα των δύο εταιριών. Απινιδωτής αξίας 12.227 ευρώ στην χώρα μας, κοστολογείται 8.190 στην Κύπρο (είναι 49% πιο ακριβός στην Ελλάδα), άλλος απινιδωτής αξίας 12.963 ευρώ στην Ελλάδα, κοστίζει 10.800 ευρώ στο σύστημα υγείας της Κύπρου. Η συνολική επιβάρυνση για το ελληνικό δημόσιο εκτιμάται περί τα 9 εκατ. ευρώ μόνο για το 2012. Εξίσου σημαντικό με την οικονομική ζημία θεωρείται και το ολιγοπώλιο που δημιούργησε ο διαγωνισμός: το 63% των προμηθειών εξειδικευμένων προϊόντων καρδιάς έχει δοθεί σε έναν και μόνο κατασκευαστή.

Αντίστοιχο ολιγοπώλιο έχει δημιουργηθεί και στο πεδίο των στέντς και των μπαλονιών αγγειοπλαστικής καρδιάς, όπου την πλειονότητα παίρνει πάλι η ίδια εταιρία, προκαλώντας την αντίδραση της Ελληνικής Καρδιολογικής Εταιρίας.

Ερωτάστε κύριε Υπουργέ :

1) Πως σχολιάζει το Υπουργείο Υγείας τα όσα αποκαλύπτονται για το θέμα των προμηθειών του ΕΣΥ, ειδικά για τα ακριβά υλικά όπως οι βηματοδότες απινιδωτές , τα στέντ, τα μπαλονάκια κλπ., που ήδη έχουν ενεργοποιήσει την δικαιοσύνη ;

2) Επειδή τα ζητήματα για τους ασθενείς είναι μείζονα και με δεδομένο, όπως επισημαίνουν ειδικοί , ότι οι συσκευές εμφυτεύονται και απαιτείται να παρακολουθούνται με την τεχνική υποστήριξη των εξειδικευμένωνκαι πιστοποιημένων τεχνικών των εταιρειών, ποιος διασφαλίζει και εγγυάται τη σωστή και συνεχή παρακολούθηση των χιλιάδων ασθενών, στους οποίους είναι ήδη εμφυτευμένες συσκευές ;

3) Διερωτάστε τι θα συμβεί, όταν μετά από μια διετία, όλοι οι ασθενείς στην Ελλάδα θα έχουν εμφυτευμένες συσκευές αποκλειστικά μιας εταιρίας και ποιος μπορεί να εγγυηθεί στους ασθενείς αυτούς ότι θα αντιμετωπισθούν επαρκώς και απρόσκοπτα τα τυχόν προβλήματα που θα ανακύψουν σε μία πιθανή εμπλοκή με το προϊόν, όπως πχ ανάκληση προϊόντος ή «λουκέτο» του αντιπροσώπου, εμπλοκή που μπορεί να αποδειχθεί μοιραία για την ζωή τους;


Αθήνα 12/9/2013

Αρ.πρ. 1552

ΟΙ ΕΡΩΤΩΝΤΕΣ ΒΟΥΛΕΥΤΕΣ

ΓΙΑΝΝΗΣ ΔΗΜΑΡΑΣ

ΓΑΒΡΙΗΛ ΑΒΡΑΜΙΔΗΣ
Αναρτήθηκε στις 5:20:00 μ.μ.

Results (English) 1:

Thursday, September 12, 2013 "continues unabated" party "supply-defibrillators and pacemakers total charge for the public € 9 million in 2012 and about 800,000 each month for the current year '
Sir,

continues unabated speculation in the party supplies the NHS, while the Greeks are insured continuous bloodletting in their medical care. Besides ...economic parameters of the commission, but is also a matter of science, as both the device purchased art products (are models of 2003), while asregards defibrillators configured monopoly situationwith only one dealer is responsible for the procurement and maintenance of equipment so keeping a peculiar 'hijacked' the Greeks heart patients living with an implantable defibrillator.

Regarding the contest GCS for the relevant commission, he dirkese 863 days (!) And by decision of 14 December 2012, the Health Procurement Commission (EPY) awarded as suppliers Pacemaker all public and military hospitals for the biennium 2013-2014,two large multinational companies by the Greek representative. One of them, as indicated by several publications, prevailed and defibrillators. The commission involved 5,000 700 pacemakers and defibrillatorstotal value of 13.5 million, with half of the amount involve defibrillators.

It was undoubtedly a "marathon" - contests, lasted 863 days.The GCS launched the tender for the supply of Pacemaker-Defibrillators for NHS hospitals on September 24, 2010 and the agreements of GCS with mainstream companies signed before a month or soon February 4, 2013.

According to the information available to the protothema.gr,2012 prices of pacemakers and defibrillators same type and age in Greece and Cyprus were within several hundred euros. Indicativea pacemaker type sensia sesr01 in Greece costs 1,346 euros while in Cyprus the same model available in 1/3 of the 'Greek' value.

Another pacemaker worth 1,812 euro in our country, available in Cyprus 709 eurosie the pacemaker is 156% more expensive in Greece. The same applies to all models of the two companies. Defibrillator worth 12,227 euros in our country, costed at 8,190 in Cyprus (is 49% more expensive in Greece)Another defibrillator worth 12,963 euros in Greece, costing 10,800 euros to the health system of Cyprus. The total charge for the Greek public is estimated around 9 million only in 2012.Just as important as the financial loss is considered and the oligopoly created the contest: 63% commissions specialized products Heart given to a single manufacturer.

Corresponding oligopoly is created and the scope of the stent and balloon angioplasty heart, where the majority takes again the same company,causing the reaction of the Greek Society of Cardiology.

Erotic Minister:

1) How says the Ministry of Health revealed what about the issue of procurement of NHSespecially for expensive materials such as defibrillators, pacemakers, stents, the balloon etc., already activated the justice?

2) Because the issues for patients is a major and given,as stated by experts that the devices are implanted and needed to be monitored with the technical support of exeidikefmenonkai certified technicians companiesWho ensures and guarantees the proper and continuous monitoring of thousands of patients that already have implanted devices?
3) wonders what will happen when after two years,all the patients in Greece have implanted devices solely of a company who can guarantee to patients that will adequately addressed seamlessly and any problems thata possible involvement of the product,such as eg product recall or 'padlock' representative, entanglement can prove fatal to their lives?




Athens 09/12/2013 Ar.pr. 1552

THE MEMBERS EROTONTES



DIMARAS JOHN GABRIEL AVRAMIDIS
Posted at 5:20:00 pm

Results (English) 2:

Thursday, September 12, 2013 "Undiminished continues the" parties ' supply of pacemakers-defibrillators and total charge for Government 9 million. Euro 2012 and about 800,000 each month for the current year "


, Ministerwith unabated intensity continues the party speculation on the NHS supplies, the time that the Greeks insured undergo continuous afaimaxeis to health care. Except ... the economic aspect of that supply, but question science arises, as the devices purchased are not products of advanced technology (2003 models), while inWhat concerns the defibrillators has fashioned monopoly, with a single representative to be responsible for the procurement and maintenance of devices thus keeping in one singular "hijacked" the Greeks heart patients living with implantable defibrillator.

In the contest of GCS, the relative supply, he dirkese 863 days (!) and decided on 14 December 2012 the Commission Health Supplies (GCS) awarded as suppliers of pacemakers of all public and military hospitals for the biennium 2013-2014, two large multinational companies by the Greek representatives. One of them, according to various reports, prevailed and the defibrillators. The supply was about 5,000 and 700 defibrillators, pacemakers total value of € 13.5 million. euros, with half of the amount to the defibrillators.

Were undoubtedly a "Marathon"-contest, lasted 863 days. The GCS launched the tender for the supply of pacemakers-defibrillators for hospitals the NHS on September 24, 2010 and accords of GCS with the prevailing companies signed about a month ago, on 4 February 2013.

According to the information available to the protothema.gr, the 2012 prices of pacemakers and defibrillators of the same type and the same age in Greece and Cyprus are off several hundred euros. Indicative, a pacemaker SENSIA SESR01 type in Greece costs 1,346 euros while in Cyprus the same model available in 1/3 of the «Greek» price.

Other pacemaker EUR 1,812 value in our country, available in Cyprus 709 euros, i.e. the pacemaker is 156% more expensive in Greece. The same happens with all models of the two companies. Defibrillator 12.227 euro value in our country, priced 8.190 in Cyprus (49% more expensive in Greece), other defibrillator 12.963 euro value in Greece, costing EUR 10,800 in the health system of Cyprus. The total charge for the Greek Government estimated about 9 million. only for Euro 2012. Just as important as the economic damage is considered and the oligopoly who created the contest: 63% of supplies of specialized products has given heart to a single manufacturer

.Corresponding oligopoly has been created, and the field of stents and balloon angioplasty of the heart, where the majority gets the same company again, causing the reaction of the Hellenic Cardiological Society.

Asks the Minister:

1) That discusses the Health Ministry as disclosed on the issue of procurement of ESI, especially for expensive materials such as pacemakers defibrillators, the stent, mpalonakia etc., that already have enabled the justice?

2) Because the issues for patients is major and given, as you point out specific, that the devices implanted and needed to be monitored with the technical support of company technical exeidikeymenwnkai certified, who ensures and guarantees the correct and constant monitoring of thousands of patients, to whom is already implanted devices?

3) Ask what will happen when after a couple of years, all patients in Greece will have implanted devices exclusively a company and who can guarantee that these patients will be treated appropriately and smoothly any problems that will in a possible involvement with the product, such as product recall or "padlock" representative, snag that may prove fatal for their life?


Athens 9/12/2013

No. PR.

the ERWTWNTES 1552 MEMBERS

YIANNIS DIMARAS

GAVRIIL AVRAMIDIS
Posted at 5: 20 pm:00 pm

Results (English) 3:

Thursday, 12 September 2013" continues unabated "Party" supply pacemaker-defibrillators and total charge for the public 9 million euros for 2012 and about 800,000 each month for the current year" a Minister,

unabated continues the party speculation on supplies of ESY, as Greek insured are suffering constant αφαιμάξεις in medical care. In addition to ...The economic aspect of the supply, but it is also a question scientific, as well as on one hand the devices purchased are not products advanced technology (are models of 2003), while in fact,What concerns the defibrillators configured monopoly situation,With a single representative to be responsible for the procurement and maintenance of devices thus holding in a quaint "Hostage" the Greek heart patients living with an implantable defibrillator.

In that regard the invitation to FPS, for the relevant supply, this δήρκεσε 863 days (!) and in its decision of 14 December 2012 the Commission supplies Health (AES) has placed as suppliers pacemakers all public and military hospitals for the years 2013-2014,Two large multinational companies by the Greek representatives. One of them, say various reports, prevailed and the defibrillators. The supply was 5,000 pacemakers and defibrillators 700,totaling 13.5 million euros, half of the amount to the defibrillators. C) It was undoubtedly a "marathon" - invitation to tender, lasted 863 days.The AES issued an invitation to tender for the supply pacemakers; defibrillators for the hospitals in ESY on 24 September 2010 and the agreements of the FPS with the prevailing companies signed about a month ago,The February 4, 2013. C) in accordance with the information in the possession of the protothema.grIn 2012, prices of pacemakers and defibrillators same type and same age in Greece and Cyprus are offset many hundreds of euros. For example,A pacemaker type SENSIA SESR01 in Greece costs 1,346 euros, while in Cyprus the same model is available in 1/3 of the "Greek" price.c) Other paced value 1,812 euros in our country, is available in Cyprus 709 euros,In other words, the pacemaker is 156% more expensive in Greece. The same is true in all models of the two companies. Defibrillator worth 12,227 euros in our country, billed 8,190 in Cyprus (is 49% more expensive in Greece),Other defibrillator worth 12,963 euros in Greece, costs 10,800 euros in health system of Cyprus. The total charge for the Greek state an estimated 9 million euros only for 2012.Just as important as the financial loss is considered and the oligopoly that created the competition: 63% of supplies specialty products heart is given in a single manufacturer.

The oligopoly has been created and the field of στέντς and balloon launch will depend pottery heart, where the majority is still the same company,Causing the reaction of Greek Cardiac Company. The covering medium Ερωτάστε Minister: Case 1) That comments on the Ministry of Health what are revealed on the issue of procurement of ESY,Especially for the expensive materials such as pacemakers defibrillators , the στέντ, μπαλονάκια etc. , which have already been turned on justice ;C) 2) because the issues for patients are major and given,As experts point out that the devices implanted and is required to be monitored with the technical support of εξειδικευμένωνκαι certified technicians of companies,Who ensure and guarantee the correct and continuous monitoring of thousands of patients, which is already implanted devices ;: 3) Ask yourself what will happen when after a period of two years,All the patients in Greece will have implanted devices only one company and who can guarantee to these patients that will be treated properly and smoothly the any problems that will beIn a possible engagement with the product,As rt recall or "lock" of the representative, involvement which can be life-threatening to the lives;


Athens 12/9/2013 Case No. below. 1552: The ΕΡΩΤΩΝΤΕΣ MEMBERS

ΓΙΑΝΝΗΣ ΔΗΜΑΡΑΣ: ΓΑΒΡΙΗΛ ΑΒΡΑΜΙΔΗΣ (posted at 5:20 AM:00 pm.